Primary Biliary Cirrhosis Drugs Market
According to Intent Market Research, the Primary Biliary Cirrhosis Drugs Market is expected to grow from USD 4.2 billion in 2024-e at a CAGR of 7.3% to touch USD 6.4 billion by 2030. The Primary Biliary Cirrhosis Drugs Market is dominated by key players such as, GlaxoSmithKline, Intercept Pharmaceut... Read More